CY1112848T1 - Αναστολεις του ιου της ηπατιτιδας c - Google Patents
Αναστολεις του ιου της ηπατιτιδας cInfo
- Publication number
- CY1112848T1 CY1112848T1 CY20121100523T CY121100523T CY1112848T1 CY 1112848 T1 CY1112848 T1 CY 1112848T1 CY 20121100523 T CY20121100523 T CY 20121100523T CY 121100523 T CY121100523 T CY 121100523T CY 1112848 T1 CY1112848 T1 CY 1112848T1
- Authority
- CY
- Cyprus
- Prior art keywords
- inhibitions
- virus
- suspension virus
- compounds
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Η παρούσα αποκάλυψη σχετίζεται με συνθέσεις (4-4'-διιμιδαζολυλ) διφαινυλίων και μεθόδους για την αγωγή της λοίμωξης από ιό της ηπατίτιδας C (ΗCV). Επίσης αποκαλύπτονται φαρμακευτικές συνθέσεις περιέχοντας τέτοιες ενώσεις και μέθοδοι για χρήση αυτών των ενώσεων στην αγωγή της λοίμωξης από ΗCV.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2008/053638 WO2009102318A1 (en) | 2008-02-12 | 2008-02-12 | Hepatitis c virus inhibitors |
EP08780411A EP2250163B1 (en) | 2008-02-12 | 2008-02-12 | Hepatitis c virus inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1112848T1 true CY1112848T1 (el) | 2016-02-10 |
Family
ID=39944252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20121100523T CY1112848T1 (el) | 2008-02-12 | 2012-06-08 | Αναστολεις του ιου της ηπατιτιδας c |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP2250163B1 (el) |
JP (1) | JP5314053B2 (el) |
KR (1) | KR101468765B1 (el) |
CN (1) | CN101998952B (el) |
AT (1) | ATE551337T1 (el) |
AU (1) | AU2008350327B2 (el) |
BR (1) | BRPI0822335A2 (el) |
CA (1) | CA2715367C (el) |
CY (1) | CY1112848T1 (el) |
DK (1) | DK2250163T3 (el) |
EA (1) | EA018782B1 (el) |
ES (1) | ES2383388T3 (el) |
HK (1) | HK1144935A1 (el) |
HR (1) | HRP20120440T1 (el) |
IL (1) | IL207468A (el) |
MX (1) | MX2010008650A (el) |
NZ (1) | NZ587323A (el) |
PL (1) | PL2250163T3 (el) |
PT (1) | PT2250163E (el) |
SI (1) | SI2250163T1 (el) |
WO (1) | WO2009102318A1 (el) |
ZA (1) | ZA201005700B (el) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7906655B2 (en) | 2008-08-07 | 2011-03-15 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US8383094B2 (en) | 2008-10-01 | 2013-02-26 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
CN102264737A (zh) | 2008-12-23 | 2011-11-30 | 雅培制药有限公司 | 抗病毒化合物 |
RU2505539C2 (ru) | 2008-12-23 | 2014-01-27 | Эбботт Лэборетриз | Антивирусные соединения |
US8188132B2 (en) | 2009-02-17 | 2012-05-29 | Enanta Pharmaceuticals, Inc. | Linked dibenzimidazole derivatives |
TWI438200B (zh) | 2009-02-17 | 2014-05-21 | 必治妥美雅史谷比公司 | C型肝炎病毒抑制劑 |
US8242156B2 (en) | 2009-02-17 | 2012-08-14 | Enanta Pharmaceuticals, Inc. | Linked dibenzimidazole derivatives |
US8394968B2 (en) | 2009-02-17 | 2013-03-12 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US9765087B2 (en) | 2009-02-27 | 2017-09-19 | Enanta Pharmaceuticals, Inc. | Benzimidazole derivatives |
US8101643B2 (en) | 2009-02-27 | 2012-01-24 | Enanta Pharmaceuticals, Inc. | Benzimidazole derivatives |
US8673954B2 (en) | 2009-02-27 | 2014-03-18 | Enanta Pharmaceuticals, Inc. | Benzimidazole derivatives |
CA2753382C (en) | 2009-02-27 | 2014-12-23 | Enanta Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
US8507522B2 (en) | 2009-03-06 | 2013-08-13 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US8796466B2 (en) | 2009-03-30 | 2014-08-05 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
TW201038559A (en) | 2009-04-09 | 2010-11-01 | Bristol Myers Squibb Co | Hepatitis C virus inhibitors |
US8143414B2 (en) | 2009-04-13 | 2012-03-27 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
RU2541571C2 (ru) | 2009-04-15 | 2015-02-20 | Эббви Инк. | Противовирусные соединения |
RS54386B8 (sr) | 2009-05-13 | 2021-06-30 | Gilead Pharmasset Llc | Antiviralna jedinjenja |
US8211928B2 (en) | 2009-05-29 | 2012-07-03 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US8138215B2 (en) | 2009-05-29 | 2012-03-20 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US8937150B2 (en) | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
US8716454B2 (en) | 2009-06-11 | 2014-05-06 | Abbvie Inc. | Solid compositions |
US9394279B2 (en) | 2009-06-11 | 2016-07-19 | Abbvie Inc. | Anti-viral compounds |
EA020031B1 (ru) | 2009-06-11 | 2014-08-29 | Эббви Бахамаз Лтд. | Противовирусные соединения |
US8221737B2 (en) | 2009-06-16 | 2012-07-17 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US8609648B2 (en) | 2009-07-02 | 2013-12-17 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
MX2012000695A (es) | 2009-07-16 | 2012-06-12 | Vertex Pharma | Análogos de bencimidazol para el tratamiento o la prevención de infecciones por flavivirus. |
JP2013500268A (ja) * | 2009-07-23 | 2013-01-07 | シャイア エルエルシー | ガランタミンアミノ酸およびペプチドプロドラッグならびにその使用 |
CN102480971B (zh) | 2009-09-04 | 2014-11-26 | 杨森制药公司 | 化合物 |
US8927709B2 (en) | 2009-09-11 | 2015-01-06 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US9156818B2 (en) | 2009-09-11 | 2015-10-13 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US8815928B2 (en) | 2009-09-11 | 2014-08-26 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US8759332B2 (en) | 2009-09-11 | 2014-06-24 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US8703938B2 (en) | 2009-09-11 | 2014-04-22 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US8822700B2 (en) | 2009-09-11 | 2014-09-02 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
UA108211C2 (uk) | 2009-11-04 | 2015-04-10 | Янссен Рід Айрленд | Бензімідазолімідазольні похідні |
US20110269956A1 (en) | 2009-11-11 | 2011-11-03 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
US20110274648A1 (en) | 2009-11-11 | 2011-11-10 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
US20110281910A1 (en) | 2009-11-12 | 2011-11-17 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
EP2512480A4 (en) | 2009-12-14 | 2013-05-15 | Enanta Pharm Inc | HEPATITIS C-VIRUS HEMMER |
US8377980B2 (en) * | 2009-12-16 | 2013-02-19 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
BR112012014899A2 (pt) | 2009-12-18 | 2017-03-14 | Idenix Pharmaceuticals Inc | composto, composição farmacêutica, método para tratar ou prevenir uma infecção por vírus de hepatite c em um sujeito, método para tratar , prevenir ou melhorar um ou mais sintomas de uma doença hepática ou distúrbio associado a uma infecção por vírus de hepatite c em um sujeito, método para inibir a replicação de um vírus em um hospedeiro, método para inibir a replicação de um vírus |
WO2011075607A1 (en) * | 2009-12-18 | 2011-06-23 | Intermune, Inc. | Novel inhibitors of hepatitis c virus replication |
US8362020B2 (en) | 2009-12-30 | 2013-01-29 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
SG188957A1 (en) | 2010-01-25 | 2013-05-31 | Enanta Pharm Inc | Hepatitis c virus inhibitors |
US8933110B2 (en) | 2010-01-25 | 2015-01-13 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
US8623814B2 (en) | 2010-02-23 | 2014-01-07 | Enanta Pharmaceuticals, Inc. | Antiviral agents |
US8178531B2 (en) | 2010-02-23 | 2012-05-15 | Enanta Pharmaceuticals, Inc. | Antiviral agents |
CA2791630A1 (en) | 2010-03-04 | 2011-09-09 | Enanta Pharmaceuticals, Inc. | Combination pharmaceutical agents as inhibitors of hcv replication |
JP2013522375A (ja) | 2010-03-24 | 2013-06-13 | バーテックス ファーマシューティカルズ インコーポレイテッド | フラビウイルス感染を処置または予防するためのアナログ |
WO2011127350A1 (en) | 2010-04-09 | 2011-10-13 | Enanta Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
WO2011146401A1 (en) * | 2010-05-17 | 2011-11-24 | Intermune, Inc. | Novel inhibitors of hepatitis c virus replication |
US8778938B2 (en) | 2010-06-04 | 2014-07-15 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
WO2011154871A1 (en) * | 2010-06-10 | 2011-12-15 | Pfizer Limited | Hepatitis c virus inhibitors |
NZ605440A (en) | 2010-06-10 | 2014-05-30 | Abbvie Bahamas Ltd | Solid compositions comprising an hcv inhibitor |
WO2012006060A1 (en) | 2010-06-28 | 2012-01-12 | Vertex Pharmaceuticals Incorporated | Compounds and methods for the treatment or prevention of flavivirus infections |
UY33473A (es) | 2010-06-28 | 2012-01-31 | Vertex Pharma | Compuestos y métodos para el tratamiento o la prevencion de infecciones por flavivirus |
US20130157894A1 (en) * | 2010-07-16 | 2013-06-20 | Jin-Hua Sun | Methods to identify combinations of ns5a targeting compound that act synergistically to inhibit hepatitis c virus replication |
US20120195857A1 (en) * | 2010-08-12 | 2012-08-02 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
US8697704B2 (en) | 2010-08-12 | 2014-04-15 | Enanta Pharmaceuticals, Inc. | Hepatitis C virus inhibitors |
WO2012024363A2 (en) | 2010-08-17 | 2012-02-23 | Vertex Pharmaceuticals Incorporated | Compounds and methods for the treatment or prevention of flaviviridae viral infections |
BR112013004520A2 (pt) | 2010-08-26 | 2016-06-07 | Univ Emory | inibidores potentes e seletivos do virus da hepatite c |
ES2701020T3 (es) | 2010-09-22 | 2019-02-20 | Alios Biopharma Inc | Nucleósidos azido y análogos nucleotídicos |
EP2635571B1 (en) | 2010-11-04 | 2015-08-12 | Theravance Biopharma R&D IP, LLC | Novel inhibitors of hepatitis c virus |
EP2640719B1 (en) | 2010-11-17 | 2017-05-10 | Gilead Pharmasset LLC | Antiviral compounds |
WO2012087976A2 (en) * | 2010-12-21 | 2012-06-28 | Intermune, Inc. | Novel inhibitors of hepatitis c virus replication |
US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
CN103687489A (zh) | 2011-05-18 | 2014-03-26 | 埃南塔制药公司 | 制备5-氮杂螺[2.4]庚烷-6-甲酸及其衍生物的方法 |
WO2013016499A1 (en) | 2011-07-26 | 2013-01-31 | Vertex Pharmaceuticals Incorporated | Methods for preparation of thiophene compounds |
WO2013016490A1 (en) | 2011-07-26 | 2013-01-31 | Vertex Pharmaceuticals Incorporated | Thiophene compounds |
WO2013021344A1 (en) | 2011-08-08 | 2013-02-14 | Lupin Limited | Imidazole derivatives as antiviral agents |
WO2013030750A1 (en) | 2011-09-01 | 2013-03-07 | Lupin Limited | Antiviral compounds |
EA026667B9 (ru) | 2011-09-16 | 2017-07-31 | Джилид Фармассет Ллс | Фармацевтическая композиция для лечения вируса гепатита с |
EA037883B1 (ru) | 2011-11-16 | 2021-05-31 | Джилид Фармассет Ллс | Противовирусные соединения |
ES2558608T3 (es) | 2011-12-28 | 2016-02-05 | Janssen Sciences Ireland Uc | Derivados hetero-bicíclicos como inhibidores del VHC |
US9034832B2 (en) | 2011-12-29 | 2015-05-19 | Abbvie Inc. | Solid compositions |
US9326973B2 (en) * | 2012-01-13 | 2016-05-03 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
IN2014MN01547A (el) | 2012-02-10 | 2015-05-08 | Lupin Ltd | |
NZ630805A (en) | 2012-03-22 | 2016-01-29 | Alios Biopharma Inc | Pharmaceutical combinations comprising a thionucleotide analog |
US20130309196A1 (en) | 2012-05-16 | 2013-11-21 | Gilead Sciences, Inc. | Antiviral compounds |
WO2014120981A1 (en) | 2013-01-31 | 2014-08-07 | Gilead Pharmasset Llc | Combination formulation of two antiviral compounds |
WO2014134251A1 (en) | 2013-02-28 | 2014-09-04 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions |
US11484534B2 (en) | 2013-03-14 | 2022-11-01 | Abbvie Inc. | Methods for treating HCV |
US20150023913A1 (en) * | 2013-07-02 | 2015-01-22 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
CN105517574B (zh) * | 2013-07-09 | 2019-01-18 | 百时美施贵宝公司 | 丙型肝炎病毒抑制剂的组合产品 |
JP2016529293A (ja) | 2013-08-27 | 2016-09-23 | ギリアド ファーマセット エルエルシー | 2つの抗ウイルス化合物の組合せ製剤 |
WO2015103490A1 (en) | 2014-01-03 | 2015-07-09 | Abbvie, Inc. | Solid antiviral dosage forms |
CN104860931A (zh) * | 2014-02-21 | 2015-08-26 | 常州寅盛药业有限公司 | 丙肝病毒抑制剂及其制药用途 |
TWI721947B (zh) | 2014-06-11 | 2021-03-21 | 美商基利法瑪席特有限責任公司 | 抗病毒化合物的固態形式 |
WO2016089814A1 (en) | 2014-12-02 | 2016-06-09 | Concert Pharmaceuticals, Inc. | Deuterated analogues of daclatasvir |
US9790207B2 (en) * | 2015-09-04 | 2017-10-17 | Alexandre Vasilievich Ivachtchenko | Pan-genomic inhibitors of NS5A protein encoded by HCV, pharmaceutical compositions, intermediates for inhibitor synthesis, and their synthesis and application methods |
JP2022510407A (ja) | 2018-12-04 | 2022-01-26 | ブリストル-マイヤーズ スクイブ カンパニー | 多重反応同位体分子種反応モニタリングによる、サンプル内検量線を用いた分析方法 |
CN109456375B (zh) * | 2018-12-11 | 2019-10-22 | 枣庄学院 | 一种抑制丙肝病毒的含单糖基杂环类化合物及制备方法 |
AU2022279234A1 (en) | 2021-05-21 | 2023-12-07 | Gilead Sciences, Inc. | Pentacyclic derivatives as zika virus inhibitors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050069522A1 (en) | 2002-08-12 | 2005-03-31 | Richard Colonno | Combination pharmaceutical agents as inhibitors of HCV replication |
DE102004036971B4 (de) | 2004-07-30 | 2009-07-30 | Advanced Micro Devices, Inc., Sunnyvale | Technik zur Bewertung lokaler elektrischer Eigenschaften in Halbleiterbauelementen |
US8143288B2 (en) * | 2005-06-06 | 2012-03-27 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
US8329159B2 (en) * | 2006-08-11 | 2012-12-11 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US7659270B2 (en) * | 2006-08-11 | 2010-02-09 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US7759495B2 (en) * | 2006-08-11 | 2010-07-20 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US7741347B2 (en) * | 2007-05-17 | 2010-06-22 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
-
2008
- 2008-02-12 AU AU2008350327A patent/AU2008350327B2/en not_active Ceased
- 2008-02-12 EP EP08780411A patent/EP2250163B1/en not_active Not-in-force
- 2008-02-12 ES ES08780411T patent/ES2383388T3/es active Active
- 2008-02-12 EA EA201001276A patent/EA018782B1/ru not_active IP Right Cessation
- 2008-02-12 PL PL08780411T patent/PL2250163T3/pl unknown
- 2008-02-12 MX MX2010008650A patent/MX2010008650A/es active IP Right Grant
- 2008-02-12 NZ NZ587323A patent/NZ587323A/en not_active IP Right Cessation
- 2008-02-12 BR BRPI0822335A patent/BRPI0822335A2/pt not_active IP Right Cessation
- 2008-02-12 DK DK08780411.8T patent/DK2250163T3/da active
- 2008-02-12 AT AT08780411T patent/ATE551337T1/de active
- 2008-02-12 PT PT08780411T patent/PT2250163E/pt unknown
- 2008-02-12 WO PCT/US2008/053638 patent/WO2009102318A1/en active Application Filing
- 2008-02-12 JP JP2010546737A patent/JP5314053B2/ja not_active Expired - Fee Related
- 2008-02-12 SI SI200830675T patent/SI2250163T1/sl unknown
- 2008-02-12 KR KR1020107020257A patent/KR101468765B1/ko not_active IP Right Cessation
- 2008-02-12 CN CN200880128704.XA patent/CN101998952B/zh not_active Expired - Fee Related
- 2008-02-12 CA CA2715367A patent/CA2715367C/en not_active Expired - Fee Related
-
2010
- 2010-08-08 IL IL207468A patent/IL207468A/en not_active IP Right Cessation
- 2010-08-10 ZA ZA2010/05700A patent/ZA201005700B/en unknown
- 2010-12-06 HK HK10111331.3A patent/HK1144935A1/xx not_active IP Right Cessation
-
2012
- 2012-05-23 HR HRP20120440AT patent/HRP20120440T1/hr unknown
- 2012-06-08 CY CY20121100523T patent/CY1112848T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2008350327B2 (en) | 2013-09-12 |
KR101468765B1 (ko) | 2014-12-04 |
JP2011511832A (ja) | 2011-04-14 |
EA018782B1 (ru) | 2013-10-30 |
EA201001276A1 (ru) | 2011-04-29 |
CN101998952B (zh) | 2014-10-08 |
WO2009102318A1 (en) | 2009-08-20 |
KR20100114924A (ko) | 2010-10-26 |
EP2250163B1 (en) | 2012-03-28 |
ATE551337T1 (de) | 2012-04-15 |
IL207468A0 (en) | 2010-12-30 |
NZ587323A (en) | 2012-02-24 |
HRP20120440T1 (hr) | 2012-06-30 |
PT2250163E (pt) | 2012-06-01 |
DK2250163T3 (da) | 2012-07-16 |
BRPI0822335A2 (pt) | 2019-09-24 |
HK1144935A1 (en) | 2011-03-18 |
MX2010008650A (es) | 2010-08-30 |
AU2008350327A1 (en) | 2009-08-20 |
PL2250163T3 (pl) | 2012-10-31 |
SI2250163T1 (sl) | 2012-08-31 |
IL207468A (en) | 2015-11-30 |
CA2715367C (en) | 2015-05-05 |
CA2715367A1 (en) | 2009-08-20 |
JP5314053B2 (ja) | 2013-10-16 |
EP2250163A1 (en) | 2010-11-17 |
CN101998952A (zh) | 2011-03-30 |
ZA201005700B (en) | 2012-01-25 |
ES2383388T3 (es) | 2012-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1112848T1 (el) | Αναστολεις του ιου της ηπατιτιδας c | |
EA200900297A1 (ru) | Ингибиторы вируса гепатита с | |
CY1119988T1 (el) | Αναστολεις του ιου της ηπατιτιδας c | |
MX2010008749A (es) | Inhibidores del virus de la hepatitis c. | |
CY1114356T1 (el) | Αναστολεις του ιου της ηπατιτιδας c | |
MA33806B1 (fr) | Inhibiteurs du virus de l'hepatite c | |
CY1114298T1 (el) | Διαμορφωτικως περιορισμενα διφαινυλ παραγωγα για χρηση ως αναστολεις ιου ηπατιτιδας c | |
TN2012000214A1 (en) | Hepatitis c virus inhibitors | |
MY152971A (en) | Hepatitis c virus inhibitors | |
MX2011008045A (es) | Inhibidores del virus de la hepatitis c. | |
WO2008021936A3 (en) | Hepatitis c virus inhibitors | |
EA201390538A1 (ru) | Противовирусные соединения | |
MX2010008699A (es) | Derivados heterociclicos como inhibidores de virus de la hepatitis c. | |
IL195025A (en) | History of compressed indolubenzazepine with cyclopropyl and pharmaceuticals containing them as an anti-hcv drug | |
EA200870164A1 (ru) | Лечение вирусного гепатита | |
MX2013001579A (es) | Inhibidores del virus de la hepatitis c | |
MX337936B (es) | Compuestos inhibidores del virus de la hepatitis c. | |
BR112013028679A2 (pt) | inibidores do vírus da hepatite c | |
MX2010001416A (es) | Compuesto para el tratamiento de la hepatitis c. | |
ATE505473T1 (de) | Cyclopropylkondensierte indolobenzazepinderivate zur behandlung von hepatitis c | |
UA108904C2 (xx) | Противірусні сполуки | |
CY1114249T1 (el) | Αναστολεις του ιου ηπατιτιδας c |